ATTRACTIVE COLOPLAST IS STILL UNATTRACTIVELY PRICED (REDUCE; 1.5% DOWNSIDE)
07/05/21 -" Coloplast (Reduce, Denmark) is, fundamentally, an attractive business (AV fundamental strength score of 9/10 vs 7.7 for AV MedTech and 5.4 for AV universe). The sector-leading return metrics tell a ..."
Pages
62
Language
English
Published on
07/05/21
You may also be interested by these reports :
23/06/26
There’s an interesting paradox at the heart of Sartorius Stedim Biotech’s (SSB; ADD; France) investment case. Since our last push in February 2025, ...
03/06/26
Despite a reduction in our target price, as discussed in the EPS section, our positive recommendation on Qiagen remains unchanged. This optimism is ...
29/05/26
Elekta’s Q4 results revealed an adjusted EBIT exceeding expectations, although sales fell short. The company offered qualitative guidance for ...
26/05/26
Piling up assets is no strategy